Johnson & Johnson To Pay $8 Billion After Male Breast Growth Was Linked To Their Anti-psychotic Drug, jury says | Maybach Media House
Johnson & Johnson will have to pay $8 billion in punitive damages after a man claims the company didn't warn young men that the drug Risperdal could grow breasts, a jury said Tuesday, according to Reuters.